Rekah Pharmaceutical Industry Ltd. - Laporan Laba Rugi (TTM)

Rekah Pharmaceutical Industry Ltd.
IL ˙ TASE ˙ IL0010810096
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Rekah Pharmaceutical Industry Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 240 265 263 273 262 264 272 275 287 292 299 309 315 322 332 324 332 322 308 312
Change (%) 10.78 -0.97 3.77 -3.94 0.72 2.95 1.38 4.15 1.91 2.24 3.28 2.12 2.02 3.32 -2.40 2.23 -2.98 -4.20 1.35
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 173 197 197 207 201 199 202 203 208 214 220 228 236 241 250 249 259 250 239 241
Change (%) 13.86 0.00 4.96 -2.79 -1.02 1.76 0.25 2.77 2.53 2.85 3.63 3.45 2.47 3.34 -0.24 3.99 -3.51 -4.11 0.51
% of Revenue 72.14 74.14 74.87 75.73 76.63 75.31 74.44 73.62 72.64 73.08 73.52 73.77 74.73 75.07 75.08 76.74 78.06 77.64 77.71 77.06
Gross Operating Profit 67 69 66 66 61 65 69 73 78 79 79 81 80 80 83 75 73 72 69 72
Change (%) 2.80 -3.75 0.23 -7.52 6.40 6.57 4.67 8.00 0.26 0.57 2.31 -1.63 0.68 3.25 -8.89 -3.58 -1.09 -4.52 4.29
% of Revenue 27.86 25.86 25.13 24.27 23.37 24.69 25.56 26.38 27.36 26.92 26.48 26.23 25.27 24.93 24.92 23.26 21.94 22.36 22.29 22.94
SG&A 47 46 45 46 47 50 53 56 60 60 61 64 68 71 75 74 74 74 73 73
Change (%) -0.86 -2.26 2.09 1.03 6.54 6.36 5.92 6.63 1.42 1.25 4.70 5.68 4.90 5.11 -0.88 -0.13 -0.29 -0.69 -0.48
% of Revenue 19.45 17.40 17.18 16.90 17.77 18.80 19.42 20.29 20.77 20.67 20.48 20.76 21.48 22.09 22.47 22.82 22.29 22.91 23.75 23.32
R&D 2 2 1 2 2 2 3 3 3 3 3 4 4 4 4 4 4 4 4 4
Change (%) -6.77 -7.72 12.16 10.03 18.56 26.18 6.74 9.09 5.66 5.82 3.10 3.74 3.28 1.43 3.21 -1.04 4.09 2.16 1.47
% of Revenue 0.69 0.58 0.54 0.59 0.67 0.79 0.97 1.02 1.07 1.11 1.14 1.14 1.16 1.17 1.15 1.22 1.18 1.27 1.35 1.35
OpEx 222 245 243 254 249 251 258 262 272 279 287 298 310 319 330 306 315 329 318 342
Change (%) 10.37 -0.45 4.47 -2.01 0.72 2.92 1.55 3.74 2.56 2.67 3.85 4.07 2.91 3.59 -7.24 3.00 4.30 -3.28 7.39
% of Revenue 92.47 92.13 92.61 93.24 95.11 95.11 95.08 95.24 94.86 95.47 95.88 96.40 98.24 99.10 99.36 94.43 95.14 102.28 103.27 109.42
Operating Income 18 21 19 18 13 13 13 13 15 13 12 11 6 3 2 18 16 -7 -10 -29
Change (%) 15.82 -7.06 -4.99 -30.49 0.69 3.59 -1.90 12.29 -10.08 -6.94 -9.88 -50.05 -47.65 -26.36 744.11 -10.79 -145.56 37.32 191.89
% of Revenue 7.53 7.87 7.39 6.76 4.89 4.89 4.92 4.76 5.14 4.53 4.12 3.60 1.76 0.90 0.64 5.57 4.86 -2.28 -3.27 -9.42
Interest Expense -5 -6 -6 -6 -6 -6 -5 -6 -6 -6 -6 -8 -9 -8 -8 -8 -7 -7 -6 -6
Change (%) 6.20 1.03 1.12 -7.31 2.38 -3.39 2.77 0.66 0.27 10.68 28.53 13.16 -8.76 -6.67 -1.42 -5.82 -6.64 -3.62 -1.16
% of Revenue -2.28 -2.19 -2.23 -2.18 -2.10 -2.13 -2.00 -2.03 -1.96 -1.93 -2.09 -2.60 -2.88 -2.58 -2.33 -2.35 -2.17 -2.09 -2.10 -2.05
Net Income 9 11 10 9 5 7 5 3 4 -2 -2 -3 -8 -7 -6 7 8 6 3 -13
Change (%) 22.55 -6.76 -9.97 -42.86 27.90 -20.40 -35.65 9.20 -155.09 -1.86 28.86 226.89 -18.10 -9.02 -208.27 12.02 -18.61 -58.17 -618.26
% of Revenue 3.68 4.07 3.83 3.32 1.98 2.51 1.94 1.23 1.29 -0.70 -0.67 -0.84 -2.68 -2.15 -1.89 2.10 2.30 1.93 0.84 -4.31

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista